WE ARE THE FIRST HEALTHCARE COMMUNICATIONS AGENCY TO SPECIALIZE IN CELL AND GENE THERAPIES
We combine expertise in cell and gene therapies with a global agency platform and extensive experience in healthcare communications
We have been working exclusively with pharmaceutical and biotechnology companies developing and commercializing cell and gene therapies for over 5 years
We are experienced in supporting companies with products in early-phase clinical development, as well as those commercializing cell and gene therapies for the first time
Answering your key questions
Communicate highly complex science
Strategy, insights and influence
Build and facilitate collaborations
Design and digital innovation
Integrated programme design
What we do
We have worked with multiple pharmaceutical and biotechnology companies, ranging from small start-ups to global organizations
We have experience in working across >35 rare diseases, including 11 cell and gene therapies
We use a range of tactics to extend the reach of data and engage multiple audiences
Seques® is part of AMICULUM®, an independent family of 11 specialist branded agencies with over 350 medical communications professionals in 13 worldwide locations.
Our team hold academic qualifications in genetics and many have practical experience of gene editing technologies.
We collaborate with the wider AMICULUM family to provide clients with the optimal team size, expertise and skills tailored for their project.